Anti-vascular endothelial growth factor dosing frequency and visual outcomes in macular oedema following branch retinal vein occlusion

OBJECTIVES: To determine the relationship between treatment frequency with intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents and visual acuity (VA) outcomes in eyes with macular oedema (MO) secondary to branch retinal vein occlusion (BRVO) in US clinical practice. METHODS: Stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Modi, Yasha S., Goduni, Lediana, Moini, Hadi, Gibson, Andrea, Boucher, Nick, Lucas, Genevieve, Dhoot, Dilsher S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630437/
https://www.ncbi.nlm.nih.gov/pubmed/37156863
http://dx.doi.org/10.1038/s41433-023-02527-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630437/
https://www.ncbi.nlm.nih.gov/pubmed/37156863
http://dx.doi.org/10.1038/s41433-023-02527-7

Ejemplares similares